VENATICUS AB
Accelerating preclinical drug development through translational expertise and lab services.
Yleiskatsaus
- 0
- Työntekijät
- 0 SEK
- Liikevaihto
- 2004
- Perustettu
Avainpäättäjät
Karin von Wachenfeldt
CEO
Patrik Holmqvist
Board member
Charlott Brunmark
CSO
Per-Ola Önnervik
Head of In Vivo
+1 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Truly Translational, founded in 2011, operates as a strategic partner in drug development, supported by its subsidiary, Truly Labs, established in 2015. The organization specializes in providing comprehensive preclinical Contract Research Organization (CRO) services alongside expert strategic consul...